Abstract
Liquid biopsies are under intense investigation for real-time monitoring of patients with cancer. This lecture will focus on analysis of circulating tumour DNA (ctDNA) and CTCs in blood. Examples will include detection of minimal residual disease and monitoring emergence of resistance to endocrine therapies in patients with breast cancer as well approaches used in other common cancers including non-small cell lung cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
